PACS Group, Inc. Increase (Decrease) in Other Accrued Liabilities
PACS Group, Inc. (PACS) reported Increase (Decrease) in Other Accrued Liabilities of $57.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2026-08-04
- PACS Group, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2026-06-30 was $43.26M, a 48.26% decline year-over-year.
- PACS Group, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2026-03-31 was $14.72M, a 33.92% decline year-over-year.
- PACS Group, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2025-12-31 was -$24.07M, a 167.03% decline year-over-year.
- PACS Group, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2025-09-30 was -$68.58M, a 315.55% decline year-over-year.
- PACS Group, Inc. increase (decrease) in other accrued liabilities for fiscal 2025 was $13.23M, a 81.93% decline from fiscal 2024.
- PACS Group, Inc. increase (decrease) in other accrued liabilities for fiscal 2024 was $73.21M.
- PACS Group, Inc. increase (decrease) in other accrued liabilities for fiscal 2023 was -$55.50M.
- PACS Group, Inc. increase (decrease) in other accrued liabilities for fiscal 2022 was -$24.39M.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $57.98M 10-Q · filed 2026-08-04 | $33.91M derived: sum of 3 quarters · filed 2026-08-04 | -$34.67M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $14.72M 10-Q · filed 2026-05-11 | -$9.35M derived: sum of 2 quarters · filed 2026-05-11 | -$77.92M derived: sum of 3 quarters · filed 2026-05-11 | $5.67M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | -$24.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$92.65M derived: sum of 2 quarters · filed 2026-02-27 | -$9.05M derived: sum of 3 quarters · filed 2026-08-04 | $13.23M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | -$68.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $15.02M derived: sum of 2 quarters · filed 2026-08-04 | $37.30M 10-Q · filed 2025-11-19 | $73.22M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | $83.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $105.88M 10-Q · filed 2026-08-04 | $141.79M derived: sum of 3 quarters · filed 2026-08-04 | $173.60M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $22.28M 10-Q · filed 2026-05-11 | $58.20M derived: sum of 2 quarters · filed 2026-05-11 | $90.01M derived: sum of 3 quarters · filed 2026-05-11 | $94.19M derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $35.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $67.73M derived: sum of 2 quarters · filed 2026-02-27 | $71.91M derived: sum of 3 quarters · filed 2026-02-27 | $73.21M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $31.81M derived: 10-Q 9 month − 10-K 6 month · filed 2025-11-19 | $35.99M derived: sum of 2 quarters · filed 2025-11-19 | $37.29M 10-Q · filed 2025-11-19 | $7.77M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $4.18M derived: 10-K 6 month − 10-K 3 month · filed 2025-11-19 | $5.48M 10-K · filed 2025-11-19 | $5.49M 10-Q · filed 2024-08-12 | -$24.05M derived: sum of 3 quarters · filed 2026-02-27 | -$13.65M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $1.30M 10-K · filed 2025-11-19 | $1.34M 10-Q · filed 2024-05-13 | -$28.22M derived: sum of 2 quarters · filed 2026-02-27 | -$17.83M derived: sum of 3 quarters · filed 2026-02-27 | -$34.26M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | -$29.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$19.13M derived: sum of 2 quarters · filed 2026-02-27 | -$35.56M derived: sum of 3 quarters · filed 2026-02-27 | -$55.50M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $10.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$6.04M derived: sum of 2 quarters · filed 2025-11-19 | -$25.98M 10-Q · filed 2025-11-19 | |||
| 2023-06-30 | -$16.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$36.37M 10-Q · filed 2024-08-12 | ||||
| 2023-03-31 | -$19.94M 10-Q · filed 2024-05-13 | |||||
| 2022-12-31 | -$24.39M 10-K · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATIONAL HEALTHCARE CORP (NHC) | United States | $3.473B | 23.65 |
| ENSIGN GROUP, INC (ENSG) | United States | $10.098B | 24.68 |